Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €2.02 EUR
Change Today -0.082 / -3.91%
Volume 9.5K
As of 12:47 PM 10/6/15 All times are local (Market data is delayed by at least 15 minutes).

aap implantate (AAQ) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/9/15 - €2.85
52 Week Low
08/24/15 - €1.85
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AAP IMPLANTATE (AAQ)

Related News

No related news articles were found.

aap implantate (AAQ) Related Businessweek News

No Related Businessweek News Found

aap implantate (AAQ) Details

aap Implantate AG, a medical device company, researches, develops, manufactures, and sells implants, medical instruments, bone cements, and replacement materials for orthopedics. It provides LOQTEQ, an anatomical angular stable plating system for compressing fractures with angular stable locking screws; and fragment set comprising T, L, quarter tubular, and reconstruction plates, as well as cortical and cancellous screws. It also offers cannulated screws for use in various fractures, as well as in anatomical regions; AcroPlate, which is used for the treatment of AC joint injuries; and autodynamic plating systems for secure fracture stabilization. In addition, the company provides a range of bone cements and accessories for application in arthroplasty, vertebroplasty, and kyphoplasty; and collagen fleeces for ambulant and stationary tissue care. Further, it offers bone substitutes that includes Artosal, a synthetic osteoconductive bone substitute; Cerabone, a ceramic bone substitute; OsteoCem, a calcium phosphate cement; Osnatal, a human bone allograft; and PerOssal, a synthetic bone substitute and carrier material. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name; and to original equipment manufacturers and private label cooperations. It operates primarily in the European Union, Asia, and the United States. aap Implantate AG is headquartered in Berlin, Germany.

218 Employees
Last Reported Date: 08/14/15

aap implantate (AAQ) Top Compensated Officers

Chairman of Management Board and Chief Execut...
Total Annual Compensation: €364.0K
Chief Finance Officer and Member of the Manag...
Total Annual Compensation: €252.0K
Compensation as of Fiscal Year 2014.

aap implantate (AAQ) Key Developments

AAP Implantate AG Announces Unaudited Consolidated Earnings Results for Second Quarter and Six Months of 2015

AAP Implantate AG announced unaudited consolidated earnings results for second quarter and six months of 2015. For the quarter, the company reported sales of EUR 6.5 million, LBITDA of EUR 0.8 million, LBIT of EUR 1.5 million compared to the sales of EUR 8.1 million, EBITDA of EUR 1.5 million, EBIT of EUR 1 million for the same quarter a year ago. For the year to date, the company reported sales of EUR 13.6 million, LBITDA of EUR 0.6 million, LBIT of EUR 1.9 million compared to the sales of EUR 14.2 million, EBITDA of EUR 1.6 million, EBIT of EUR 0.5 million for the same period a year ago.

AAP Implantate AG, Q2 2015 Earnings Call, Aug 17, 2015

AAP Implantate AG, Q2 2015 Earnings Call, Aug 17, 2015

aap Implantate AG Reports Sales Results for the Second Quarter and First Half of Fiscal Year 2015

aap Implantate AG reported sales results for the second quarter and first half of fiscal year 2015. For the quarter, the company generated sales totaling EUR 6.5 million against EUR 8.1 million a year ago. Total sales in the first half thus amounted to EUR 13.6 million against EUR 14.2 million a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AAQ:GR €2.02 EUR -0.082

AAQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AAQ.
View Industry Companies

Industry Analysis


Industry Average

Valuation AAQ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.0x
Price/Book 1.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AAP IMPLANTATE, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at